All posts by: Michael Zand

About Michael Zand

SVCE students win global award – Business Line

Continue reading

2018-02-08 NEWS

SVCE students win global award
Business Line
Thirteen students of the Chennai-based Sri Venkateswara College of Engineering (SVCE) have won the silver medal in ‘iGEM 2017’ competition. The iGEM is an international biotechnology competition held in Boston every year; SVCE students have won an

Continue reading

2018-02-08 NEWS

Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema …
GlobeNewswire (press release)
Herantis Pharma Plc (“Herantis”) has completed the patient enrolment in the clinical Phase 1 safety and tolerability study with the company’s investigational gene therapy product Lymfactin® for the treatment of breast cancer associated secondary

and more »

Continue reading

2018-02-08 NEWS

New Jersey Herald

2nd man undergoes gene editing; no major side effects showing so far
New Jersey Herald
A second patient has been treated in a historic gene editing study in California, and no major side effects or safety issues have emerged from the first man’s treatment nearly three months ago, doctors revealed Tuesday. Gene editing is a more precise

and more »

Continue reading

2018-02-08 NEWS

New Atlas

New CRISPR method strategically targets gene mutations to correct DMD heart defect
New Atlas
Researchers at UT Southwestern Medical Center have developed a CRISPR technique to efficiently correct the function of heart cells in patients with Duchenne muscular dystrophy (DMD). It involves making a single cut at strategic points along patient’s